TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.0590nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
Affinity DataKi: 0.0600nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 1(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.100nMAssay Description:Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.More data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.100nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
Affinity DataKi: 0.210nMAssay Description:In vitro inhibition of human leukocyte elastase mediated hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNAMore data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 1(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.300nMAssay Description:Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.More data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.300nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.380nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.380nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.390nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 1(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.More data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
Affinity DataKi: 0.410nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.430nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.480nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 3(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.490nMAssay Description:Displacement of [125I]- ANP from the Atrial Natriuretic Peptide Clearance Receptor.More data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 1(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.490nMAssay Description:Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.More data for this Ligand-Target Pair
Affinity DataKi: 0.5nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.580nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.620nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.630nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.640nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.640nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
TargetAtrial natriuretic peptide receptor 1(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 0.650nMAssay Description:Displacement of [125I]- ANP from the Atrial natriuretic peptide receptor A.More data for this Ligand-Target Pair
Affinity DataKi: 0.650nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.650nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.810nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.810nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.850nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 0.850nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.870nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.960nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.960nMAssay Description:In vitro inhibition of human leukocyte elastase mediated hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNAMore data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:In vitro inhibitory activity against human leukocyte elastase was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.5nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Binding affinity for human leukocyte elastaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:In vitro inhibition of human leukocyte elastase mediated hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNAMore data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Inhibitory activity against Human Neutrophil Elastase using acute lung injury model (ALIM) assayMore data for this Ligand-Target Pair